Neuraxis, INC
Data quality: 100%
NRXS
NYSE
Manufacturing
Measuring & Analyzing Instruments
$7.22
▲
$0.12
(1.69%)
Mkt Cap: 80.77 M
Price
$7.22
Mkt Cap
80.77 M
Day Range
$6.97 — $7.28
52-Week Range
$1.33 — $7.97
Volume
91,716
Open $7.11
50D / 200D Avg
$5.80
24.41% above
50D / 200D Avg
$3.65
97.86% above
Quick Summary
Key Takeaways
Debt/Equity of 0.09 — conservative balance sheet
Negative free cash flow of -6.46 M
Capital efficient — spends only 0.87% of revenue on capex
Growth
Revenue Growth (5Y)
N/A
Revenue (1Y)32.89%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
-238.61%
Below sector avg (-53.41%)
ROIC-160.94%
Net Margin-218.55%
Op. Margin-219.37%
Safety
Debt / Equity
0.09
Below sector avg (0.31)
Current Ratio1.58
Interest Coverage-105.85
Valuation
PE (TTM)
-10.36
Below sector avg (-1.48)
P/B Ratio35.35
EV/EBITDAN/A
Dividend YieldN/A
Price History
Financial Trends
Peer Comparison
vs Manufacturing sector median (1364 peers)
Peer Comparison
vs Manufacturing sector median (1364 peers)| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -10.4 | -1.5 |
| P/B | 35.4 | 1.6 |
| ROE % | -238.6 | -53.4 |
| Net Margin % | -218.6 | -41.5 |
| Rev Growth 5Y % | — | 1.8 |
| D/E | 0.1 | 0.3 |
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 32.89% | Revenue Growth (3Y) | 20.45% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 3.57 M | Net Income (TTM) | -7.80 M |
| ROE | -238.61% | ROA | -121.27% |
| Gross Margin | 84.23% | Operating Margin | -219.37% |
| Net Margin | -218.55% | Free Cash Flow (TTM) | -6.46 M |
| ROIC | -160.94% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.09 | Current Ratio | 1.58 |
| Interest Coverage | -105.85 | Asset Turnover | 0.55 |
| Working Capital | 1.84 M | Tangible Book Value | 2.00 M |
| Dividends | |||
| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -10.36 | Forward P/E | N/A |
| P/B Ratio | 35.35 | P/S Ratio | 22.63 |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | -8.00% | ||
| Market Cap | 80.77 M | Enterprise Value | 76.59 M |
| Per Share | |||
| EPS (Diluted TTM) | -0.95 | Revenue / Share | 0.32 |
| FCF / Share | -0.58 | OCF / Share | -0.58 |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
| Efficiency | |||
| CapEx / Revenue | 0.87% | FCF Conversion | 82.87% |
| SBC-Adj. FCF | -6.90 M | Growth Momentum | N/A |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Revenue | 3.57 M | 2.69 M | 2.46 M |
| Net Income | -7.80 M | -8.24 M | -14.63 M |
| EPS (Diluted) | -0.95 | -1.22 | -4.50 |
| Gross Profit | 3.01 M | 2.32 M | 2.16 M |
| Operating Income | -7.83 M | -7.16 M | -6.66 M |
| EBITDA | — | — | — |
| R&D Expenses | 493,611.0 | 206,107.0 | 169,315.0 |
| SG&A Expenses | — | — | — |
| D&A | 59,501.0 | 37,831.0 | 40,725.0 |
| Interest Expense | 73,969.0 | 174,328.0 | 476,416.0 |
| Income Tax | — | — | — |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Total Assets | 6.40 M | 4.76 M | 509,498.0 |
| Total Liabilities | 3.00 M | 2.69 M | 1.91 M |
| Shareholders' Equity | 3.40 M | 2.07 M | -1.40 M |
| Total Debt | 148,293.0 | 154,152.0 | 376,404.0 |
| Cash & Equivalents | 4.97 M | 3.70 M | 78,560.0 |
| Current Assets | 5.73 M | 4.27 M | 242,610.0 |
| Current Liabilities | 2.79 M | 2.43 M | 1.89 M |
{"event":"ticker_viewed","properties":{"ticker":"NRXS","listing_kind":"stock","pathname":"/stocks/nrxs","exchange":"NYSE","country":"US"}}